These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 26737337)
21. Therapeutic Effects of an Anti-Gravity Treadmill (AlterG) Training on Neuromuscular Abnormalities Associated with Spasticity in Children with Cerebral Palsy Noroozi S; Mehrabi R; Lotfian M; Nooshiravan F; Shahroki A; Irani A; Mirbagheri MM Annu Int Conf IEEE Eng Med Biol Soc; 2020 Jul; 2020():3856-3859. PubMed ID: 33018842 [TBL] [Abstract][Full Text] [Related]
22. [The usefulness of tizanidine. A one-year follow-up of the treatment of spasticity in infantile cerebral palsy]. Vásquez-Briceño A; Arellano-Saldaña ME; León-Hernández SR; Morales-Osorio MG Rev Neurol; 2006 Aug 1-15; 43(3):132-6. PubMed ID: 16871477 [TBL] [Abstract][Full Text] [Related]
23. The effect of robot-assisted lokomotor training on gait recovery: a multivariate analysis. Niu X; Patel C; Varoqui D; Mirbagheri MM Annu Int Conf IEEE Eng Med Biol Soc; 2011; 2011():3542-5. PubMed ID: 22255104 [TBL] [Abstract][Full Text] [Related]
24. A double-blind, placebo-controlled trial of tizanidine in the treatment of spasticity caused by multiple sclerosis. United Kingdom Tizanidine Trial Group. Neurology; 1994 Nov; 44(11 Suppl 9):S70-8. PubMed ID: 7970014 [TBL] [Abstract][Full Text] [Related]
25. [Spastic syndrome and main directions of its treatment]. Damulin IV Zh Nevrol Psikhiatr Im S S Korsakova; 2003; 103(12):4-9. PubMed ID: 14763249 [No Abstract] [Full Text] [Related]
26. Robotic-assisted locomotor training enhances ankle performance in adults with incomplete spinal cord injury. Krishnan V; Kindig M; Mirbagheri M J Rehabil Med; 2016 Oct; 48(9):781-786. PubMed ID: 27630015 [TBL] [Abstract][Full Text] [Related]
27. An approach to switching patients from baclofen to tizanidine. Brenner R; Hyman N; Knobler R; O'Brien M; Stephan T Hosp Med; 1998 Oct; 59(10):778-82. PubMed ID: 9850294 [TBL] [Abstract][Full Text] [Related]
28. Comparative profile of tizanidine in the management of spasticity. Lataste X; Emre M; Davis C; Groves L Neurology; 1994 Nov; 44(11 Suppl 9):S53-9. PubMed ID: 7970011 [TBL] [Abstract][Full Text] [Related]
29. Effects of multijoint spastic reflexes of the legs during assisted bilateral hip oscillations in human spinal cord injury. Onushko T; Hyngstrom A; Schmit BD Arch Phys Med Rehabil; 2010 Aug; 91(8):1225-35. PubMed ID: 20684903 [TBL] [Abstract][Full Text] [Related]
30. Electrophysiological analysis of the mode of action of muscle relaxants in spasticity. Delwaide PJ Ann Neurol; 1985 Jan; 17(1):90-5. PubMed ID: 3985591 [TBL] [Abstract][Full Text] [Related]
31. Cost-effectiveness comparison of tizanidine and baclofen in the management of spasticity. Rushton DN; Lloyd AC; Anderson PM Pharmacoeconomics; 2002; 20(12):827-37. PubMed ID: 12236804 [TBL] [Abstract][Full Text] [Related]
32. Update on tizanidine for muscle spasticity and emerging indications. Malanga G; Reiter RD; Garay E Expert Opin Pharmacother; 2008 Aug; 9(12):2209-15. PubMed ID: 18671474 [TBL] [Abstract][Full Text] [Related]
33. Intrathecal baclofen in subjects with spastic hemiplegia: assessment of the antispastic effect during gait. Rémy-Néris O; Tiffreau V; Bouilland S; Bussel B Arch Phys Med Rehabil; 2003 May; 84(5):643-50. PubMed ID: 12736875 [TBL] [Abstract][Full Text] [Related]
34. A multi-centre, double-blind trial of tizanidine, a new antispastic agent, in spasticity associated with hemiplegia. Bes A; Eyssette M; Pierrot-Deseilligny E; Rohmer F; Warter JM Curr Med Res Opin; 1988; 10(10):709-18. PubMed ID: 3286129 [TBL] [Abstract][Full Text] [Related]
35. Mechanisms of tizanidine action on spasticity. Milanov I; Georgiev D Acta Neurol Scand; 1994 Apr; 89(4):274-9. PubMed ID: 8042446 [TBL] [Abstract][Full Text] [Related]
36. A double-blind comparative trial of new muscle relaxant, tizanidine (DS 103-282), and baclofen in the treatment of chronic spasticity in multiple sclerosis. Smolenski C; Muff S; Smolenski-Kautz S Curr Med Res Opin; 1981; 7(6):374-83. PubMed ID: 7016449 [TBL] [Abstract][Full Text] [Related]
37. Role of tizanidine in the treatment of spasticity. Neurology; 1994 Nov; 44(11 Suppl 9):S1-80. PubMed ID: 7970005 [No Abstract] [Full Text] [Related]
38. Flexor reflex for assessment of common interneurone activity in spasticity. Milanov IG Electromyogr Clin Neurophysiol; 1992 Dec; 32(12):621-9. PubMed ID: 1493777 [TBL] [Abstract][Full Text] [Related]
39. Distinguishing active from passive components of ankle plantar flexor stiffness in stroke, spinal cord injury and multiple sclerosis. Lorentzen J; Grey MJ; Crone C; Mazevet D; Biering-Sørensen F; Nielsen JB Clin Neurophysiol; 2010 Nov; 121(11):1939-51. PubMed ID: 20457538 [TBL] [Abstract][Full Text] [Related]
40. Botulinum neurotoxin versus tizanidine in upper limb spasticity: a placebo-controlled study. Simpson DM; Gracies JM; Yablon SA; Barbano R; Brashear A; J Neurol Neurosurg Psychiatry; 2009 Apr; 80(4):380-5. PubMed ID: 18977811 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]